Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q4 FY26

Sunil Healthcare Q4 FY26 Results: Net Profit ₹1.5 Cr, Up 275.0% YoY

Sunil Healthcare Ltd reported revenue from operations of ₹19.7 Cr (-7.1% YoY) and net profit of ₹1.5 Cr (+275.0% YoY) for Q4 FY26.

Q4 FY26 at a glance · ₹ crore
MetricQ4 FY26Q3 FY26Q4 FY25
Revenue from operations19.721.821.2
Other income0.40.50.5
Total income20.122.321.7
Profit before exceptional items & tax-0.80.80.3
Exceptional items-0.10.00.0
Profit before tax-0.90.80.3
Net profit1.50.60.4
Operating margin-4.5%3.6%1.4%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year+275.00%
Net profit, quarter on quarter+150.00%
Revenue, year on year-7.10%
Source

BSE results filing, NSE: SUNLOC. Figures extracted from the filing.

Read the filing ↗

Sunil Healthcare Ltd: key numbers

Share price
₹70.50
Market cap
₹72.30 Cr
Revenue (annual)
₹87.72 Cr
Net profit (annual)
₹4.01 Cr
P/E (TTM)
20.3×Sector 50.4×
Promoter holding
73.53%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sunil Healthcare Ltd

All →
17:48 IST BSE
Annual General Meeting

Sunil Healthcare Annual General Meeting

Sunil Healthcare Ltd announced its 52nd AGM on September 28, 2026, with remote e-voting available from September 25 to September 27, 2026.

16:16 IST BSE
Annual Report

Sunil Healthcare Annual Report

Sunil Healthcare Ltd has submitted its Annual Report for the financial year 2025-26. The report includes the notice for the 52nd Annual General Meeting.

15:51 IST BSE
Annual General Meeting

Sunil Healthcare Annual General Meeting

Sunil Healthcare Limited has issued a notice for its 52nd Annual General Meeting scheduled for September 28, 2026. The meeting will address financial statement adoption and re-appointment.